Expert Opinion: Prof. Dr. Johan Maertens presents his highlights from EBMT 2024

Join Prof. Dr. Johan Maertens as he shares key insights and takeaways from the EBMT Congress 2024, held in Glasgow, UK. His discussion centers on infectious complications following CAR-T therapy and stem cell transplantation, with a particular focus on the management of cytomegalovirus infections. The congress also showcased updates on innovative  CMV treatment options and advanced management strategies presented during various sessions. 

Discover more insights from Prof. Dr. Maertens in the video below!

Please see below the links to the abstracts that Prof. Dr. Maertens is referring to in the video:  

MARIBAVIR USE FOR REFRACTORY CMV INFECTION/DISEASE: THE RESULTS FROM THE FRENCH COMPASSIONATE PROGRAMME 

PHYSICIAN PERSPECTIVES ON THE BURDEN AND CLINICAL MANAGEMENT OF CYTOMEGALOVIRUS (CMV) INFECTION IN TRANSPLANT RECIPIENTS IN CENTRAL AND EASTERN EUROPE  

REAL-WORLD OUTCOMES AND TREATMENT PATTERNS OF CMV INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS, REFRACTORY OR INTOLERANT TO TREATMENTS IN EUROPE, CANADA, ISRAEL: INTERIM ANALYSIS